Objective-Despite a wealth of experimental data in animal models, the independent association of insulin resistance with early carotid atherosclerosis in man has not been demonstrated. Approach and Results-We studied a European cohort of 525 men and 655 women (mean age, 44±8 years) free of conditions known to affect carotid wall (diabetes mellitus, hypertension, and dyslipidemia). All subjects received an oral glucose tolerance test, a euglycemic hyperinsulinemic clamp (M/I as a measure of insulin sensitivity), and B-mode carotid ultrasound. In 833 participants (380 men), the carotid ultrasound was repeated after 3 years. In men, baseline intimamedia thickness in the common carotid artery (CCA-IMT) was significantly higher (P<0.05) in the lowest M/I tertile, whereas in women CCA-IMT was higher (P<0.0005) in the highest fasting plasma glucose tertile (after adjustment for established risk factors). In multiple regression models, with CCA-IMT as the dependent variable and with risk factors and univariate metabolic correlates as independent variables, circulating free fatty acids and the leptin:adiponectin ratio replaced M/I as independent metabolic determinants of CCA-IMT in men. The strongest metabolic determinant of CCA-IMT in women was fasting plasma glucose. Three-year CCA-IMT changes were not associated with any cardiometabolic risk factor. Conclusions-In young-to-middle aged apparently healthy people, the association of CCA-IMT with insulin sensitivity and its metabolic correlates differs between men and women. Lower insulin sensitivity is associated with higher IMT only in men; this association seems to be mediated by circulating free fatty acids and adipocytokines. In women, CCA-IMT is independently associated with fasting plasma glucose. (Arterioscler Thromb Vasc The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/on behalf of the RISC Investigators*
R educed insulin sensitivity (IS) is considered a primary pathophysiologic mechanism linking together several metabolic and hemodynamic abnormalities that may result in accelerated atherosclerosis and increased risk for cardiovascular diseases. Whether the blunted response to insulin has a direct role in the development of atherosclerotic changes within the arterial wall or whether its proatherogenic effect is mediated by the associated systemic abnormalities, such as hyperglycemia, hypertension, dyslipidemia, or chronic inflammation, is not clear. Early atherosclerotic processes, including subendothelial retention of apolipoprotein B-containing lipoproteins, activation of endothelial cells, recruitment of monocytes, foam cell formation, and migration of smooth muscle cells to the intima, might be directly or indirectly influenced by insulin resistance alone or in combination with hyperinsulinemia and hyperglycemia. [1] [2] [3] [4] [5] [6] Carotid intima-media thickness (IMT) is a generally accepted marker of early subclinical atherosclerosis, and several clinical studies have evaluated the effect of IS and fasting plasma insulin levels on the carotid wall. [7] [8] [9] [10] [11] [12] [13] [14] However, the results of these studies have not been conclusive, probably because of differences in the methods used to estimate IS, characteristics of the study populations (including people with other conditions possibly directly influencing carotid wall thickness), and also because of the lack of adequate adjustment for established risk factors.
The aim of the Relationship Between Insulin Sensitivity and Cardiovascular Risk (RISC) study 15 was to test the association among IS, carotid IMT, and the presence of early carotid plaques, cross-sectionally and prospectively, in a relatively large and apparently healthy European population free of confounding morbidities, such as hypertension, diabetes mellitus, dyslipidemia, chronic inflammatory, or cardiovascular diseases (Figure 1 ). IS was measured by the gold-standard method of the euglycemic hyperinsulinemic clamp, and all associations were evaluated separately for men and women and further controlled for conventional cardiovascular risk factors and habitual physical activity (PA). 16 Carotid IMT was measured at the level of common carotid artery (CCA) because previous studies have demonstrated that traditional risk factors 17 and metabolic variables 18 account for a greater proportion of IMT variability in the CCA than in the carotid bulb or internal carotid artery, and that the reproducibility of measurements is better for CCA than for other carotid segments. 19 The presence of plaques, however, was evaluated in the entire extracranial carotid tree as one of the first and the most common site of early atherosclerotic plaque formation is carotid bifurcation. 20 In addition, we assessed the association of carotid wall thickness and plaque presence with recognized metabolic correlates of blunted insulin signaling, such as an increase in triglycerides, circulating free fatty acids (FFA), apolipoprotein B level, inflammatory markers, and adipocytokines. [21] [22] [23] 
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
At baseline, men and women differed in insulin sensitivity (M/I) and in all cardio-metabolic risk factors (Table 1) , except for smoking habits, high-sensitive C-reactive protein, and 2-hour plasma glucose and insulin levels. Average daily PA, as assessed by accelerometer monitoring, was also comparable between the 2 sexes (mean monitoring time, 5.7±1.5 days). One hundred sixty-one women (24%) were postmenopausal. During the 3-year period, there were increases in body mass index (+0.3±1.6 kg/m 2 ; P<0.0001), fat mass (+1.0±4.7 kg; P<0.0001), waist circumference (+1.1±6.3 cm; P<0.0001), systolic blood pressure (BP; +2.4±12.1 mm Hg; P<0.00001), and plasma glucose concentrations (+0.12±0.59 mmol/L; P=0.001) and decreases in heart rate (−2.2±9.2 bpm; P<0.0001) and high-density lipoprotein-cholesterol (−0.03±0.31 mmol/L; P=0.001), whereas low-density lipoprotein (LDL)-cholesterol (+0.03±0.63 mmol/L; P=0.18), triglycerides (+0.04±0.58 mmol/L; P=0. 14) , and plasma insulin concentrations (+2.1±19.4 pmol/L; P=0.11) did not change significantly. These changes did not differ between men and women. Thirty-two men and 25 women started pharmacological treatment for high BP, dyslipidemia, or glucose intolerance/diabetes mellitus during the follow-up period.
CCA-IMT values showed a positively skewed distribution. At baseline, CCA-IMT was higher in men than women ( Table 2) . Carotid plaques, if present, were localized in carotid bulb or origin of internal carotid artery, and their prevalence and thickness were comparable between the 2 sexes. Over the 3-year period, CCA-IMT changes were small, if significantly different from zero (P<0.0001), and they did not differ between men and women. In men, plaque presence after 3 years was higher than at baseline (P<0.0001) and higher than in women.
We next examined baseline CCA-IMT, 3-year IMT changes, and carotid plaque presence across tertiles of IS (M/I), fasting, and 2-hour plasma glucose and insulin levels ( Table 3 ) and homeostasis model assessment of insulin resistance (not shown), separately in men and women, and after adjustment for recruitment center and established atherosclerotic risk factors (age, systolic BP, LDL-cholesterol, current smoking, and menopausal status). Three-year IMT changes were also adjusted for baseline IMT and for therapeutic interventions if started during the follow-up period. In men, baseline CCA-IMT was significantly higher in the lowest M/I tertile (P<0.05); in women, baseline CCA-IMT was higher in the highest tertile of fasting glucose (P<0.0005; Figure 2 ). CCA-IMT did not differ across tertiles of 2-hour plasma glucose or insulin in either sex or across tertiles of homeostasis model assessment of insulin resistance. Three-year CCA-IMT changes ( Table 3) did not differ across tertiles of tested metabolic measures. Plaque presence in men was comparable across tertiles of the tested parameters, either at baseline or at 3 years; in women, plaque presence was higher in the highest glucose tertile at both time points (Table 3) . Impaired fasting glucose (IFG), impaired glucose tolerance, or both during baseline oral glucose tolerance test were detected, respectively, in 117, 33, or 17 men and in 61, 46, or 16 women. In men, there were no differences in carotid parameters between individuals with normal glucose tolerance and those with IFG or impaired glucose tolerance ( Table I in the online-only Data Supplement). In contrast, women with IFG, but not those with impaired glucose tolerance, had higher baseline CCA-IMT (P=0.005) and carotid plaque presence, both at baseline (P<0.01) and at 3 years (P<0.05), as compared with women with normal glucose tolerance. The subgroups did not differ for 3-year IMT changes.
A complete correlation matrix was generated, including baseline CCA-IMT, 3-year CCA-IMT changes, CCA-IMT inidicates baseline intima-media thickness in the common carotid artery; and M/I, insulin sensitivity. *P value for the differences in baseline CCA-IMT, ΔCCA-IMT, or plaque presence across tertiles of the variables in bold type adjusted for recruiting center, age, systolic blood pressure, low-density lipoprotein-cholesterol, current smoking, menopausal status and, in the case of ΔCCA-IMT, also for baseline CCA-IMT and 3-year therapeutic interventions.
In the subgroups of men (n=328) and women (n=456) undergoing accelerometer monitoring, average daily PA was directly related to M/I (ρ=0.17 and 0.21; P<0.005 and <0.0001) and inversely to waist circumference (ρ=−0.15 and −0.17; P<0.01 and <0.001), fat mass (ρ=−0.21 and −0.19; P<0.0005 and <0.0001), fasting insulin (ρ=−0.23 and −0.19; P<0.0001 for both), and the leptin:adiponectin ratio (ρ=−0.17 and −0.23; P<0.005 and <0.0001). In men only, PA was inversely related to LDL-cholesterol and triglycerides (ρ=−0.16 and -0.21; P<0.005 and <0.0005) and in women to systolic BP and baseline CCA-IMT (ρ=−0.14 and −0.14; P<0.005 for both). Habitual PA was comparable in men and women with and without carotid plaques (data not shown).
Multiple regression models, with standardized baseline CCA-IMT as the dependent variable and established risk factors (age, systolic BP, LDL-cholesterol, current smoking, and menopause) as independent variables, were run separately for men and women. After backward stepwise removal, independent determinants of baseline CCA-IMT were age, systolic BP, and LDL-cholesterol in men, and age, systolic BP, and current smoking in women. M/I, when added into the models (Table 4 , model A), was independently related to baseline CCA-IMT only in men. When other univariate anthropometric and metabolic correlates were included (Table 4 , model B), FFA and the leptin:adiponectin ratio replaced M/I in men, whereas in women, fat mass, fasting glucose, and triglycerides entered as additional independent determinants of baseline CCA-IMT. When daily PA was also added into the model, it did not influence the independent association between CCA-IMT and FFA in men nor the association between CCA-IMT and fasting plasma glucose in women ( Table III in 
the onlineonly Data Supplement).
Models A and B were also run separately for lean and overweight/obese (body mass index=25-39.9 kg/m 2 ) men and women (Table IV in CCA-IMT was LDL-cholesterol. Fasting plasma glucose was independently related to baseline CCA-IMT only in overweight/obese women, in whom LDL-cholesterol also entered as additional IMT determinant ( Table IV in the online-only  Data Supplement) .
Independent determinants of carotid plaque presence in men were age and LDL-cholesterol both at baseline and at 3 years (R 2 =0.15 and 0.17; P<0.005 for both). In women, independent determinants of plaque presence were age, current smoking, and fasting glucose at baseline (R 2 =0.19; P<0.0001), and age, menopausal status, and fasting glucose at 3 years (R 2 =0.24; P<0.0001). The percentage with plaques did not differ between lean and overweight/obese men either at baseline (5.6% versus 9.5%; P=0.10) or at 3 years (8.1% versus 13.9%; P=0.08), nor in women at baseline (6.9% versus 7.0%; P=0.93) or at 3 years (6.5% versus 7.9%; P=0.57).
Discussion
To our knowledge, this is the first study in which the association between IS, measured directly by the euglycemic hyperinsulinemic clamp technique, and carotid IMT has been explored in a relatively large cohort of individuals free of hypertension, diabetes mellitus, or dyslipidemia, and in which results have been analyzed separately for men and women and controlled for established atherosclerotic risk factors. It is important to emphasize that in people with hypertension, diabetes mellitus, or dyslipidemia, it may not be possible to separate the potential atherogenic effect of an impaired tissue response to insulin from the known impact of clinically manifest disease. It is also firmly established that IS, some cardiovascular risk factors, and carotid IMT exhibit definite sex-related differences. 24, 25 In our healthy men, in particular in overweight and obese men, lower IS was associated with higher baseline CCA-IMT independently of established risk factors. However, the association between CCA-IMT and M/I was eliminated on introducing FFA and the leptin:adiponectin ratio into the prediction model. This result suggests that in men, plasma FFA and adipocytokines might link insulin resistance with increase in carotid IMT, especially in the presence of increased body fat. Abnormal insulin signaling in adipose tissue results in inappropriate lipolysis and elevations in circulating FFA, 21 as well as an increase in proatherogenic leptin 22 and a decrease in antiatherogenic adiponectin. 23 Indeed, in the present data set, FFA levels and the leptin:adiponectin ratio were related to M/I and adiposity, inversely and directly, respectively ( Table II in  the online-only Data Supplement) .
Circulating FFA and adipocytokines may induce structural changes in the vascular wall through different pathways. Circulating FFA have been shown to stimulate vascular smooth muscle cell proliferation and migration 26 and to modify the expression of genes controlling extracellular matrix formation 2, 27 ; at the endothelial level, FFA may induce oxidative stress, apoptosis, and an inflammatory response. 28 Leptin exerts its proatherogenic effect through stimulation of an inflammatory reaction and vascular smooth muscle cell proliferation, 29 whereas adiponectin is supposed to attenuate inflammation and to inhibit proliferation of smooth muscle cells induced by growth factors. 30 The role of insulin resistance and FFA or adipocytokines in carotid atherosclerosis has also been suggested by other studies. In renal transplant recipients with a high prevalence of insulin resistance, carotid IMT was independently associated with plasma FFA. 31 In patients with type 2 diabetes mellitus, FFA-rich areas were demonstrated within carotid plaques, 32 and the degree of carotid stenosis was related with plasma FFA. 33 An association between carotid IMT and the leptin:adiponectin ratio has been reported both in patients with type 2 diabetes mellitus 34 and healthy men. 35 Interestingly, the independent association between baseline CCA-IMT and FFA was detected in men but not women, who, despite being more insulin sensitive, had higher levels of circulating FFA, probably because of higher body adiposity (Table 1 ). This discrepancy might reflect the differences in endogenous antioxidant capacity, which seemingly is higher in female than in male sex. 36, 37 In women, fasting plasma glucose was an important determinant of carotid wall thickness and early plaque presence, which were both higher in women in the top tertile of fasting plasma glucose, with fasting glucose levels ranging from 5.2 to 6.8 mmol/L (ie, well below the diabetic range). The independent association between fasting plasma glucose and baseline CCA-IMT was also confirmed in a multiple regression models, although only for overweight/obese women. Finally, both baseline CCA-IMT and plaque presence were higher in women with IFG. In contrast, no association was demonstrated between CCA-IMT or plaque presence and 2-hour glucose, and women with impaired glucose tolerance had carotid measures comparable with those of women with normal glucose metabolism. These data contribute to the still open discussion on the role of fasting and postchallenge glucose levels in macrovascular disease and cardiovascular risk 38 and are in agreement with the suggestion of the American Diabetes Association to lower the IFG diagnostic threshold to 5.6 mmol/L, 39 as well as with the results of a meta-analysis, demonstrating that the relative cardiovascular risk associated with plasma glucose level is higher for nondiabetic women than men. 40 The rationale for the sex-specific relationship between plasma glucose and markers of atherosclerosis or cardiovascular risk is still unclear, but it is supposed to reflect the differences in other cardiovascular risk factors. 40 In the men of this study, the strongest metabolic determinant of carotid wall thickness and plaque presence was LDL-cholesterol, which might overrule the proatherogenic effect of glucose. 2 Plasma glucose can directly provoke structural changes in the vascular wall by a variety of mechanisms: endothelial dysfunction, vascular smooth muscle cell proliferation, and inflammatory phenotype change in macrophages. 1, 2, 6 In addition, in the current data, women in the highest tertile of fasting glucose had a significantly higher leptin:adiponectin ratio as compared with women in the lower tertiles ( . This observation suggests that circulating adipocytokines, whose secretion seems to be influenced by glucose levels, 41 may participate in the proatherogenic action of plasma glucose.
CCA-IMT progression did not correlate with any cardiometabolic risk factors or with their changes but only with age and baseline IMT values, directly and inversely, respectively. The lack of correlations between IMT progression rate and risk factors may be related to a lower precision of IMT progression measurements, which show substantially higher within-subject variance than baseline IMT measures. 19, 42 However, it must be considered that the use of progression data in a healthy population probably requires a longer follow-up period, during which significant changes in risk load can develop and consequently influence the carotid wall. 42 In our population, the main determinants of baseline CCA-IMT did not change substantially during a 3-year period. For this reason, a subset of the the RISC population is being followed up, and additional evaluations of carotid IMT and risk load are planned at 10 years. The inverse relationship between IMT progression and baseline IMT values was apparent also in a healthy population of Young Finns study and was explained by regression to the mean 43 ; however, it might reflect a physiological vascular remodeling aimed to maintain low wall tensile stress of the artery by increasing the thickness of its wall. 44 
Study Limitations
Conventional ultrasound scanners and not radiofrequencybased wall-tracking systems were used; therefore, indices of carotid stiffness representing a very early marker of vascular damage could not be measured. Information about menopause, smoking habit, and therapy was obtained by self-reported questionnaires and not verified. Another limitation of our study is the loss of 29% of participants during the follow-up. However, cross-sectional and longitudinal cohorts were comparable for sex distribution, body mass, and IS, and the difference in age was <1 year (Figure 1 ). As discussed above, the 3-year followup period was probably too short for evaluating the impact of cardio-metabolic risk factors on IMT progression rate in healthy people. Finally, the population of the present study consists of healthy young-to-middle aged whites, and we cannot rule out that a different pattern of associations may be found in older populations, different ethnic groups, or in selected cohorts of subjects with advanced atherosclerotic disease.
Conclusions
In young-to-middle aged European participants without confounding comorbidities, the association of carotid IMT or plaque presence with IS and its metabolic correlates differs between men and women. In men, especially if overweight/ obese, a lower IS is associated with higher carotid IMT. This association seems to be mediated by higher circulating FFA and by the mutual relation between adipocytokines with proatherogenic and antiatherogenic properties. In women, especially if overweight/obese, both CCA-IMT and plaque presence are independently associated with fasting plasma glucose levels. Collectively, these data provide new insight into the role of sex, adiposity, and IS in the development of early atherosclerotic changes.
